Financials

  • Market Capitalization 6.27 M
  • Employee 6
  • Founded 2016
  • CEO N/A
  • Website www.alzamend.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZMXG7M8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.43
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4770
ACXP
Acurx Pharmaceuticals, Inc. - Common Stock
1.23 USD-3.91%-5.38%-12.14%-35.94%6.48 M USD
4776
ENVB
Enveric Biosciences, Inc. - Common Stock
1.43 USD-2.72%-3.38%-3.38%-41.75%6.40 M USD
4779
TRAW
Traws Pharma, Inc. - Common Stock
0.41 USD-2.38%-21.15%-29.31%-85.81%6.30 M USD
4786
IMNN
Imunon, Inc. - Common Stock
1.03 USD-3.74%-14.17%-29.93%-68.31%5.78 M USD

Notizie